FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in California, United States

Biotech startups that raised Series B in California, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in California, United States
One-time CSV
  • 236 funded companies, 211 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~california-united-states.csv236 rows × 18 columns
CompanyCityLast roundAmountDate
Prolific MachinesEmeryvilleSeries B$50.0M2026-10-14
Multiply LabsSan FranciscoSeries B$75.0M2026-10-06
Moonwalk BiosciencesSouth San FranciscoSeries B$70.0M2026-09-08
N-Power MedicineRedwood CitySeries B$32.0M2026-09-01
Aureka BiotechnologiesLaguna HillsSeries B$100.0M2026-08-10
LTZ TherapeuticsSan FranciscoSeries B$38.0M2026-05-06
Unnatural ProductsSanta CruzSeries B$45.0M2026-03-16
BreezeBioBrisbaneSeries B$60.0M2026-02-25

8 rows of the CSV in 5 of its 18 columns.

236
Startups
$19.4B
Total raised
31
Funded in the last 12 months
$2.4B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 236
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence San Francisco Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
N-Power Medicine N-Power Medicine is a biotechnology company that uses AI to offer clinical research and drug development services. Artificial intelligence Redwood City Series B $32.0M 2026-09-01 $104.0M Merck Global Health Innovation Fund 101 to 250 2021
Aureka Biotechnologies Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. Artificial intelligence Laguna Hills Series B $100.0M 2026-08-10 $168.4M K2VC, NRL Capital 11 to 50 2023
LTZ Therapeutics LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. Biotech San Francisco Series B $38.0M 2026-05-06 $125.0M Qiming Venture Partners, Shunwei Capital, K2VC +1 11 to 50 2022
Unnatural Products Unnatural Products is a biotech company that develops macrocyclic peptide drug therapies. Artificial intelligence Santa Cruz Series B $45.0M 2026-03-16 $83.0M Abstract, Better Ventures, Artis Ventures +2 11 to 50 2017
BreezeBio BreezeBio is a biotechnology company that develops genetic therapies using non-viral delivery to clinically important tissues. Artificial intelligence Brisbane Series B $60.0M 2026-02-25 $127.7M Sequoia Capital, National Science Foundation, Qiming Venture Partners +1 51 to 100 2016
Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
Aeovian Pharmaceuticals Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. Biotech San Francisco Series B $55.0M 2025-12-16 $142.0M Sofinnova Investments, venBio Partners, Apollo Health Ventures 1 to 10 2012
BlossomHill Therapeutics BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. Biotech San Diego Series B $84.0M 2025-12-10 $257.0M OrbiMed, Cormorant Asset Management, Vivo Capital +2 11 to 50 2020
Profluent Bio Profluent Bio designs new proteins and gene-editing tools using AI for medicine, agriculture, and science. Artificial intelligence Emeryville Series B $106.0M 2025-11-19 $150.0M Insight Partners, Spark Capital, AIX Ventures +1 11 to 50 2022
Gate Bioscience Gate Bioscience is a biotechnology company developing small molecule treatments for hard-to-treat diseases. Biotech Brisbane Series B $65.0M 2025-11-13 $125.0M Andreessen Horowitz, Google Ventures, ARCH Venture Partners +1 11 to 50 2021
Avenzo Therapeutics Avenzo Therapeutics develops oncology therapies for treating cancer. Biotech San Diego Series B $60.0M 2025-09-04 $841.9M New Enterprise Associates, Sands Capital Ventures, Lilly Asia Ventures +2 11 to 50 2022
Actio Biosciences Actio Biosciences develops drugs for rare diseases through its research center. Biotech San Diego Series B $66.0M 2025-06-18 $121.0M Canaan Partners, Euclidean Capital, Deerfield Management +2 11 to 50 2021
Sirius Therapeutics Sirius Therapeutics is a biotechnology company developing RNAi therapies for cardiovascular diseases. Biotech San Diego Series B $50.0M 2025-05-09 $110.0M OrbiMed, Hankang Capital, Creacion Ventures +1 11 to 50 2021
Gallant Gallant advances investigational stem cell therapies to extend the healthy years of pets. Biotech San Diego Series B $18.0M 2025-03-15 $44.0M Alumni Ventures, Bling Capital, Science +2 11 to 50 2018
PictorLabs PictorLabs offers virtual staining technology powered by its proprietary artificial intelligence models. Artificial intelligence Los Angeles Series B $30.0M 2024-09-18 $48.8M Insight Partners, M Ventures 11 to 50 2019
Human Longevity Unicorn Human Longevity is a genomics-based health intelligence company supporting proactive healthcare. Biotech San Diego Series B $39.8M 2024-08-21 $369.8M StartUp Health, Amino Capital, Threshold +1 51 to 100 2013
Santa Ana Bio Santa Ana Bio develops precision immunology therapies for autoimmune and inflammatory diseases. Biotech Alameda Series B $125.0M 2024-06-13 $176.0M Andreessen Horowitz, Google Ventures, TPG +2 11 to 50 2022
AltruBio AltruBio develops targeted antibody therapeutics for cancer and immune-related inflammatory diseases. Biotech Los Altos Series B $225.0M 2024-05-21 $327.6M RA Capital Management, Blackstone, Cormorant Asset Management +2 11 to 50 2000
Elegen Elegen is a biotechnology company that develops microfluidic technology. Biotech Menlo Park Series B $35.0M 2024-05-14 $37.0M Andreessen Horowitz, 8VC, AME Cloud Ventures +1 11 to 50 2017
Capstan Therapeutics Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases. Biotech San Diego Series B $175.0M 2024-03-20 $340.0M RA Capital Management, OrbiMed, Alexandria Venture Investments +2 101 to 250 2021
Trace Genomics Trace Genomics analyzes soil genetics to help farmers improve their agricultural practices and crop yields. Biotech Burlingame Series B $10.5M 2024-02-20 $50.2M AgFunder, S2G Investments, Refactor +1 11 to 50 2015
HI-Bio HI-Bio develops therapies for immune-mediated diseases. Biotech South San Francisco Series B $95.0M 2024-01-04 $215.0M ARCH Venture Partners, Alpha Wave Global, Viking Global Investors +1 101 to 250 2021
MBrace Therapeutics MBrace Therapeutics is a privately held biopharmaceutical company. Biotech San Diego Series B $85.0M 2023-11-14 $110.0M Venrock, TPG, Alta Partners +2 11 to 50 2019
Genome Insight Genome Insight develops a platform for whole genome sequence analysis and interpretation. Biotech La Jolla Series B $23.0M 2023-11-01 DSC Investment, Schmidt, InterVest Co. +1 11 to 50 2020
Tentarix Biotherapeutics Tentarix Biotherapeutics creates protein therapeutics with combined bioactivities using synthetic biology. Biotech San Diego Series B $35.0M 2023-09-06 $93.0M Versant Ventures, Samsara BioCapital, Amplitude Venture Capital 11 to 50 2020
Metagenomi Metagenomi uses metagenomics and machine learning to discover genome editing systems for therapeutics. Artificial intelligence Emeryville Series B $100.0M 2023-01-05 $466.7M RA Capital Management, Bristol-Myers Squibb, Marshall Wace +1 101 to 250 2018
Valitor Valitor develops novel methods for modifying therapeutic proteins to control their pharmacological properties. Biotech Berkeley Series B $28.0M 2022-10-05 $39.0M SkyDeck Berkeley, Berkeley SkyDeck Fund, Morningside +2 1 to 10 2010

Table 1. Biotech startups that raised Series B in California, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 236.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Mirador Therapeutics Mirador Therapeutics develops precision medicines for immune-mediated diseases. Biotech San Diego Series B $250.0M 2026-01-12 $730.0M OrbiMed, Fidelity, ARCH Venture Partners +1 11 to 50 2024
2 Profluent Bio Profluent Bio designs new proteins and gene-editing tools using AI for medicine, agriculture, and science. Artificial intelligence Emeryville Series B $106.0M 2025-11-19 $150.0M Insight Partners, Spark Capital, AIX Ventures +1 11 to 50 2022
3 Aureka Biotechnologies Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. Artificial intelligence Laguna Hills Series B $100.0M 2026-08-10 $168.4M K2VC, NRL Capital 11 to 50 2023
4 BlossomHill Therapeutics BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. Biotech San Diego Series B $84.0M 2025-12-10 $257.0M OrbiMed, Cormorant Asset Management, Vivo Capital +2 11 to 50 2020
5 Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence San Francisco Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
6 Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence South San Francisco Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
7 BreezeBio BreezeBio is a biotechnology company that develops genetic therapies using non-viral delivery to clinically important tissues. Artificial intelligence Brisbane Series B $60.0M 2026-02-25 $127.7M Sequoia Capital, National Science Foundation, Qiming Venture Partners +1 51 to 100 2016
8 Aeovian Pharmaceuticals Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. Biotech San Francisco Series B $55.0M 2025-12-16 $142.0M Sofinnova Investments, venBio Partners, Apollo Health Ventures 1 to 10 2012
9 Prolific Machines Prolific Machines develops light-controlled gene expression systems for producing therapeutics. Artificial intelligence Emeryville Series B $50.0M 2026-10-14 $147.0M SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 51 to 100 2020
10 Unnatural Products Unnatural Products is a biotech company that develops macrocyclic peptide drug therapies. Artificial intelligence Santa Cruz Series B $45.0M 2026-03-16 $83.0M Abstract, Better Ventures, Artis Ventures +2 11 to 50 2017

Table 2. Biotech startups that raised Series B in California, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 ARCH Venture Partners Venture capital firm Chicago, United States 5 2% 2 Moonwalk Biosciences, Mirador Therapeutics
2 OrbiMed Private equity firm New York, United States 5 2% 2 Mirador Therapeutics, BlossomHill Therapeutics
3 Google Ventures Corporate venture arm San Francisco, United States 4 2% 1 Moonwalk Biosciences
4 Versant Ventures Venture capital firm Menlo Park, United States 4 2%
5 Andreessen Horowitz Venture capital firm Menlo Park, United States 4 2%
6 Alumni Ventures Angel group Manchester, United States 4 2%
7 Samsara BioCapital Private equity firm Palo Alto, United States 4 2%
8 RA Capital Management Startup incubator Boston, United States 4 2%
9 Alpha Wave Global Private equity firm Miami, United States 3 1% 1 Moonwalk Biosciences
10 Digitalis Ventures Venture capital firm New York, United States 3 1%
11 Bristol-Myers Squibb Venture capital firm New York, United States 3 1%
12 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 2 1% 1 Prolific Machines
13 SOSV Venture capital firm Princeton, United States 2 1% 1 Prolific Machines
14 Y Combinator Startup accelerator Mountain View, United States 2 1% 1 Multiply Labs
15 Khosla Ventures Venture capital firm Menlo Park, United States 2 1% 1 Moonwalk Biosciences

Table 3. Biotech startups that raised Series B in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 203 86% $17.2B
Software 39 17% $3.1B
Artificial intelligence 23 10% $2.1B
Hardware 8 3% $269.0M
Cybersecurity 3 1% $320.7M
Fintech 2 1% $282.7M
Commerce 1 0% $74.4M
Energy 1 0% $74.4M

Table 4. Biotech startups that raised Series B in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 236 100% $33.5M

Table 5. Biotech startups that raised Series B in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Diego 53 22%
San Francisco 34 14%
South San Francisco 15 6%
Palo Alto 13 6%
Menlo Park 10 4%
Redwood City 9 4%
Irvine 9 4%
Emeryville 7 3%
San Jose 6 3%
Mountain View 5 2%
Hayward 5 2%
Los Angeles 5 2%

Table 6. Biotech startups that raised Series B in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 3 10% $205.0M
September 2026 4 13% $132.0M
August 2026 4 13% $291.0M
July 2026 2 6% $130.0M
June 2026 3 10% $388.8M
May 2026 1 3% $38.0M
April 2026 3 10% $264.0M
March 2026 1 3% $45.0M
February 2026 1 3% $60.0M
January 2026 4 13% $413.8M
December 2025 4 13% $284.0M
November 2025 1 3% $106.0M

Table 7. Biotech startups that raised Series B in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 26 11% $2.0B
2025 21 9% $1.4B
2024 26 11% $1.7B
2023 13 6% $711.2M
2022 18 8% $645.4M
2021 28 12% $1.7B

Table 8. Biotech startups that raised Series B in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 8 3%
2020 to 2022 35 15%
2015 to 2019 76 32%
2010 to 2014 50 21%
Before 2010 67 28%

Table 9. Biotech startups that raised Series B in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 40 17%
11 to 50 129 55%
51 to 100 40 17%
101 to 250 15 6%
501 to 1,000 4 2%
1,001 to 5,000 1 0%
5,001 to 10,000 2 1%
10,001 or more 2 1%

Table 10. Biotech startups that raised Series B in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in California, United States whose last round is Series B are on the list?
236, in the file dated 16 November 2026. 31 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 236 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in California, United States: 236 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in California

Other sectors that raised Series B in California

Cite: FundingWatcher, 236 biotech companies in California, United States whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/california-united-states/